Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Remimazolam for Premedication in Pediatric Patients: a Double-blinded Randomized Clinical Trial

NCT04720963 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Wenzhou Medical University as lead sponsor.

NCT NCT04720963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04720963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Remimazolam for Premedication in Pediatric Patients: a Double-blinded Randomized Clinical Trial
Lead sponsor
Second Affiliated Hospital of Wenzhou Medical University
Phase
Phase 4
Overall status
Completed
Start date
February 7, 2021
Completion date
February 28, 2022
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sedative; anxiety disorder